Page 381 - PROGRAMME2018

Wednesday, 4 July 2018
08:30 - 09:30 Guerbet
“Lipiodol HSG: the therapeutic effects of a diagnostic HSG- Emerging data” Chair: Antoine Watrelot, France
Co-chair: Velja Mijatovic, The Netherlands
• Infertility workup- HSG is not dead, back to the future Antoine Watrelot, France
• HGS with Lipiodol practice Velja Mijatovic, The Netherlands
• Lipiodol Uterine Bathing or Tubal Flushing - Overview of Evidence up to 2018 Neil Johnson, New Zealand
• Therapeutic effect of oil-based- versus water-based contrast for hysterosalpingography (HSG) during the fertility work-up
Ben Mol, Australia
12:00 – 13:00 Lo.Li. Pharma International
Inositols for him and for her: from pre-clinical to clinical
Main Chairman: Professor Nicolàs Mendoza (Spain)
Second Chairman: Professor Arturo Bevilacqua from the University of Rome
• Treatment with myo-inositol and D-chiro-inositol (40:1) successfully reverses polycystic ovary syndrome in an experimental mouse model (about preclinical new studies on the use of Myo-inositol and D-Chiro-Inositol in mouse models)
Professor Mariano Bizzarri - Eminent oncologist and researcher at the university of Rome
• Therapeutic roles of Inositol stereoisomers in the physiopathology of PCOS and related infertility (about the use of inositols in the management of PCOS and related fertility)
Professor Zdravko Kamenov - Endocrinologist at the University of Sofia
• Therapeutic roles of Inositol in the management of oligoasthenoteratozoospermia (about the use of Inositols in male infertility)
Professor Aldo Calogero - Professor of Andrology at the University of Catania
FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018
381
COMPANY SYMPOSIA